These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32238109)

  • 1. Influence of toilet access on antiretroviral adherence intention among pregnant and breastfeeding women who are HIV-positive and enrolled in Option B.
    Nutor JJ; Slaughter-Acey JC; Marquez SP; DiMaria-Ghalili RA; Momplaisir F; Jemmott LS
    Health Care Women Int; 2021 Mar; 42(3):261-275. PubMed ID: 32238109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of attitudes and beliefs on antiretroviral treatment adherence intention among HIV-positive pregnant and breastfeeding women in Zambia.
    Nutor JJ; Slaughter-Acey JC; Marquez SP; DiMaria-Ghalili RA; Momplaisir F; Oladimeji KE; Jemmott LS
    BMC Public Health; 2020 Sep; 20(1):1410. PubMed ID: 32938415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water Access and Adherence Intention Among HIV-Positive Pregnant Women and New Mothers Receiving Antiretroviral Therapy in Zambia.
    Nutor JJ; Marquez S; Slaughter-Acey JC; Hoffmann TJ; DiMaria-Ghalili RA; Momplaisir F; Opong E; Jemmott LS
    Front Public Health; 2022; 10():758447. PubMed ID: 35433591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Between Counseling and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Enrolled in Option B.
    Nutor JJ; Slaughter-Acey JC; Afulani PA; Obimbo MM; Mojola SA
    AIDS Educ Prev; 2020 Oct; 32(5):378-391. PubMed ID: 33112676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral therapy among HIV infected pregnant women in public health sectors: a pilot of Chilenje level one Hospital Lusaka, Zambia.
    Mukosha M; Chiyesu G; Vwalika B
    Pan Afr Med J; 2020; 35():49. PubMed ID: 32537054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
    Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
    PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania.
    Zacharius KM; Basinda N; Marwa K; Mtui EH; Kalolo A; Kapesa A
    PLoS One; 2019; 14(2):e0212587. PubMed ID: 30794633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
    Tesfaye DJ; Hibistu DT; Abebo TA; Asfaw FT; Lukas K; Laelago T; Turuse EA; Kebede HG; Altaye AA; Bekele FB
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):82. PubMed ID: 30819147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel scale for antiretroviral therapy readiness among pregnant women in urban Zambia with newly diagnosed HIV infection.
    Mubiana-Mbewe M; Bosomprah S; Saroj RK; Kadota J; Koyuncu A; Thankian K; Vinikoor MJ
    AIDS Res Ther; 2023 Apr; 20(1):21. PubMed ID: 37024961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.
    Chi BH; Mutale W; Winston J; Phiri W; Price JT; Mwiche A; Ayles H; Stringer JSA
    Pediatr Infect Dis J; 2018 Nov; 37(11):1137-1141. PubMed ID: 29601456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
    Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O
    Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Protocol for a Cluster Randomized Trial on the Effect of a "feeding buddy" Program on adherence to the Prevention of Mother-To-Child-Transmission Guidelines in a Rural Area of KwaZulu-Natal, South Africa.
    Reimers P; Israel-Ballard K; Spies L; Tanser F; Thior I; Scott Gordon W; Coutsoudis A
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S130-6. PubMed ID: 27355500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
    Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
    BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV.
    Omonaiye O; Kusljic S; Nicholson P; Mohebbi M; Manias E
    Int J Infect Dis; 2019 Apr; 81():225-230. PubMed ID: 30790723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Enhanced Adherence Package on Early ART Uptake Among HIV-Positive Pregnant Women in Zambia: An Individual Randomized Controlled Trial.
    Mubiana-Mbewe M; Bosomprah S; Kadota JL; Koyuncu A; Kusanathan T; Mweebo K; Musokotwane K; Mulenga PL; Chi BH; Vinikoor MJ
    AIDS Behav; 2021 Mar; 25(3):992-1000. PubMed ID: 33033996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.